CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

iGOT1-01 50mg  | ≥98%

CSNpharm

iGOT1-01 is a potent aspartate aminotransferase 1 (glutamate oxaloacetate transaminase 1; GOT1) inhibitor. iGOT1-01 has IC50s of 85 μM and 11.3 μM in MDH coupled GOT1 enzymatic assay and GOT1/GLOX/HRP assay, respectively. iGOT1-01 has anti-cancer activity.

More Information Supplier Page

iGOT1-01 5mg  | ≥98%

CSNpharm

iGOT1-01 is a potent aspartate aminotransferase 1 (glutamate oxaloacetate transaminase 1; GOT1) inhibitor. iGOT1-01 has IC50s of 85 μM and 11.3 μM in MDH coupled GOT1 enzymatic assay and GOT1/GLOX/HRP assay, respectively. iGOT1-01 has anti-cancer activity.

More Information Supplier Page

iGOT1-01 25mg  | ≥98%

CSNpharm

iGOT1-01 is a potent aspartate aminotransferase 1 (glutamate oxaloacetate transaminase 1; GOT1) inhibitor. iGOT1-01 has IC50s of 85 μM and 11.3 μM in MDH coupled GOT1 enzymatic assay and GOT1/GLOX/HRP assay, respectively. iGOT1-01 has anti-cancer activity.

More Information Supplier Page

iGOT1-01 100mg  | ≥98%

CSNpharm

iGOT1-01 is a potent aspartate aminotransferase 1 (glutamate oxaloacetate transaminase 1; GOT1) inhibitor. iGOT1-01 has IC50s of 85 μM and 11.3 μM in MDH coupled GOT1 enzymatic assay and GOT1/GLOX/HRP assay, respectively. iGOT1-01 has anti-cancer activity.

More Information Supplier Page

iGOT1-01 10mg  | ≥98%

CSNpharm

iGOT1-01 is a potent aspartate aminotransferase 1 (glutamate oxaloacetate transaminase 1; GOT1) inhibitor. iGOT1-01 has IC50s of 85 μM and 11.3 μM in MDH coupled GOT1 enzymatic assay and GOT1/GLOX/HRP assay, respectively. iGOT1-01 has anti-cancer activity.

More Information Supplier Page

Iguratimod 10mg  | ≥99%

CSNpharm

Iguratimod is a selective inhibitor of COX2 (IC50 = 20 μM/7.7 μg/mL) and several inflammatory cytokines including interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor, it’s an anti-inflammatory agent.

More Information Supplier Page

Iguratimod 5mg  | ≥99%

CSNpharm

Iguratimod is a selective inhibitor of COX2 (IC50 = 20 μM/7.7 μg/mL) and several inflammatory cytokines including interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor, it’s an anti-inflammatory agent.

More Information Supplier Page

Iguratimod 50mg  | ≥99%

CSNpharm

Iguratimod is a selective inhibitor of COX2 (IC50 = 20 μM/7.7 μg/mL) and several inflammatory cytokines including interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor, it’s an anti-inflammatory agent.

More Information Supplier Page

IITZ-01 1mg  | ≥98%

CSNpharm

IITZ-01 is an inhibitor of lysosomotropic autophagy. It can enhance autophagosome accumulation and inhibit autophagosomal degradation that finally resulting in the inhibition of autophagy.

More Information Supplier Page

IITZ-01 25mg  | ≥98%

CSNpharm

IITZ-01 is an inhibitor of lysosomotropic autophagy. It can enhance autophagosome accumulation and inhibit autophagosomal degradation that finally resulting in the inhibition of autophagy.

More Information Supplier Page

IITZ-01 50mg  | ≥98%

CSNpharm

IITZ-01 is an inhibitor of lysosomotropic autophagy. It can enhance autophagosome accumulation and inhibit autophagosomal degradation that finally resulting in the inhibition of autophagy.

More Information Supplier Page

IITZ-01 5mg  | ≥98%

CSNpharm

IITZ-01 is an inhibitor of lysosomotropic autophagy. It can enhance autophagosome accumulation and inhibit autophagosomal degradation that finally resulting in the inhibition of autophagy.

More Information Supplier Page

IITZ-01 10mg  | ≥98%

CSNpharm

IITZ-01 is an inhibitor of lysosomotropic autophagy. It can enhance autophagosome accumulation and inhibit autophagosomal degradation that finally resulting in the inhibition of autophagy.

More Information Supplier Page

IITZ-01 100mg  | ≥98%

CSNpharm

IITZ-01 is an inhibitor of lysosomotropic autophagy. It can enhance autophagosome accumulation and inhibit autophagosomal degradation that finally resulting in the inhibition of autophagy.

More Information Supplier Page

IKK 16 HCl 100mg  | ≥98%

CSNpharm

IKK 16 HCl is a selective inhibitor of IκB kinase (IKK) with IC50s of 40, 70 and 200 nM for IKKβ, IKK complex and IKKα respectively.

More Information Supplier Page

IKK 16 HCl 25mg  | ≥98%

CSNpharm

IKK 16 HCl is a selective inhibitor of IκB kinase (IKK) with IC50s of 40, 70 and 200 nM for IKKβ, IKK complex and IKKα respectively.

More Information Supplier Page

IKK 16 HCl 50mg  | ≥98%

CSNpharm

IKK 16 HCl is a selective inhibitor of IκB kinase (IKK) with IC50s of 40, 70 and 200 nM for IKKβ, IKK complex and IKKα respectively.

More Information Supplier Page

IKK 16 HCl 10mg  | ≥98%

CSNpharm

IKK 16 HCl is a selective inhibitor of IκB kinase (IKK) with IC50s of 40, 70 and 200 nM for IKKβ, IKK complex and IKKα respectively.

More Information Supplier Page

Ilicic Acid 5mg  | ≥98%

CSNpharm

Ilicic acid is a natural product isolated and purified from the bark of Laggera pterodonta with anti-hyperglycemic and anti-inflammatory activities.

More Information Supplier Page

Ilicic Acid 1mg  | ≥98%

CSNpharm

Ilicic acid is a natural product isolated and purified from the bark of Laggera pterodonta with anti-hyperglycemic and anti-inflammatory activities.

More Information Supplier Page

Imatinib 250mg  | ≥99%

CSNpharm

Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

More Information Supplier Page